BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination

NCT03991442 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Fimasartan/Amlodipine

Sponsor

Boryung Pharmaceutical Co., Ltd